Interrelationship between Mini-Mental State Examination scores and biochemical parameters in patients with mild

Ramasamy Vasantharekha1, Hannah P Priyanka1, Thangavel Swarnalingam2

  • 1Integrative Medicine Laboratory, Department of Biotechnology, SRM University, Kattankulathur, Tamil Nadu, India.

Abstract

Insights

This study in Tamil Nadu found that high cholesterol levels are linked to Alzheimer's disease (AD) and cognitive decline. Biochemical markers in AD patients may offer new diagnostic targets.

Area of Science:

  • Neurology
  • Biochemistry
  • Gerontology

Background:

  • Mild cognitive impairment (MCI) and Alzheimer's disease (AD) prevalence and risk factors require further investigation, particularly in diverse populations.
  • Understanding the relationship between cognitive function and biochemical parameters is crucial for early diagnosis and management.

Purpose of the Study:

  • To determine the prevalence of MCI and AD in Tamil Nadu, India.
  • To explore the association between cognitive function and biochemical markers in individuals with MCI and AD.

Main Methods:

  • A cohort study involving 3126 adults in Tamil Nadu, with 1337 participants followed up for 12 months.
  • Cognitive function assessed using Mini-Mental State Examination (MMSE) scores.
  • Biochemical analyses included lipid profiles and liver function tests from blood samples.

Main Results:

  • Alzheimer's disease patients exhibited significantly lower MMSE scores compared to controls and MCI groups, with a further decline over one year.
  • AD patients showed altered serum lipid profiles: lower high-density lipoprotein, alkaline phosphatase, and bilirubin; higher low-density lipoprotein, total cholesterol, and triglycerides.
  • MMSE scores positively correlated with high-density lipoprotein and negatively with other lipid parameters in AD patients.

Conclusions:

  • Hypercholesterolemia is identified as a potential risk factor for Alzheimer's disease, contributing to neurotoxicity and cognitive impairment.
  • Lipoprotein and heme metabolism dysfunctions present potential targets for AD diagnosis.
  • The study highlights the importance of biochemical markers in understanding and diagnosing AD.